A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

Conexeu Sciences Inc., a Reno-based regenerative medicine company, commenced trading on the Nasdaq on May 21, 2026, with a preclinical-stage bioregenerative extracellular matrix platform (CXU™) targeting multiple markets including breast reconstruction, wound care, and periodontal applications, with a planned 510(k) submission in early 2027.